{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:03:50Z","timestamp":1791428630689,"version":"4.3.3"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT23-17"],"award-info":[{"award-number":["SU2C-AACR-DT23-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["FC001169"],"award-info":[{"award-number":["FC001169"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["FC001169"],"award-info":[{"award-number":["FC001169"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["FC001169"],"award-info":[{"award-number":["FC001169"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK Cancer Research UK Lung Cancer Centre of Excellence Rosetrees Trust Butterfield and Stoneygate Trusts Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["ID16584"],"award-info":[{"award-number":["ID16584"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["RP\/EA\/180007"],"award-info":[{"award-number":["RP\/EA\/180007"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009730","name":"Stand Up To Cancer","doi-asserted-by":"publisher","award":["SU2C-AACR-DT23-17"],"award-info":[{"award-number":["SU2C-AACR-DT23-17"]}],"id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"FP7","doi-asserted-by":"publisher","award":["FP7-THESEUS-617844"],"award-info":[{"award-number":["FP7-THESEUS-617844"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Commission ITN","award":["607722"],"award-info":[{"award-number":["607722"]}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["835297"],"award-info":[{"award-number":["835297"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","award":["665233"],"award-info":[{"award-number":["665233"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK Breast Cancer Children's Cancer and Leukaemia Group NIH","doi-asserted-by":"publisher","award":["U54 CA217376"],"award-info":[{"award-number":["U54 CA217376"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK Breast Cancer Children's Cancer and Leukaemia Group NIH","doi-asserted-by":"publisher","award":["R01 CA185138"],"award-info":[{"award-number":["R01 CA185138"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1U01 CA224012"],"award-info":[{"award-number":["1U01 CA224012"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U2C CA233280"],"award-info":[{"award-number":["U2C CA233280"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA223150"],"award-info":[{"award-number":["R01 CA223150"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01"],"award-info":[{"award-number":["R01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA226909"],"award-info":[{"award-number":["R01 CA226909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 HD099367"],"award-info":[{"award-number":["R21 HD099367"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Before squamous cell lung cancer develops, precancerous lesions can be found in the airways. From longitudinal monitoring, we know that only half of such lesions become cancer, whereas a third spontaneously regress. Although recent studies have described the presence of an active immune response in high-grade lesions, the mechanisms underpinning clinical regression of precancerous lesions remain unknown. Here, we show that host immune surveillance is strongly implicated in lesion regression. Using bronchoscopic biopsies from human subjects, we find that regressive carcinoma in situ lesions harbor more infiltrating immune cells than those that progress to cancer. Moreover, molecular profiling of these lesions identifies potential immune escape mechanisms specifically in those that progress to cancer: antigen presentation is impaired by genomic and epigenetic changes, CCL27\u2013CCR10 signaling is upregulated, and the immunomodulator TNFSF9 is downregulated. Changes appear intrinsic to the carcinoma in situ lesions, as the adjacent stroma of progressive and regressive lesions are transcriptomically similar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Immune evasion is a hallmark of cancer. For the first time, this study identifies mechanisms by which precancerous lesions evade immune detection during the earliest stages of carcinogenesis and forms a basis for new therapeutic strategies that treat or prevent early-stage lung cancer.<\/jats:p>\n                    <jats:p>See related commentary by Krysan et al., p. 1442.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 1426<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-19-1366","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T14:45:11Z","timestamp":1595256311000},"page":"1489-1499","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer"],"prefix":"10.1158","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-0250","authenticated-orcid":false,"given":"Adam","family":"Pennycuick","sequence":"first","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor H.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4411-4435","authenticated-orcid":false,"given":"Khalid","family":"AbdulJabbar","sequence":"additional","affiliation":[{"name":"2Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom."},{"name":"3Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1097-1738","authenticated-orcid":false,"given":"Shan E. Ahmed","family":"Raza","sequence":"additional","affiliation":[{"name":"2Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom."},{"name":"3Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom."},{"name":"4Department of Computer Science, University of Warwick, Coventry, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-7230","authenticated-orcid":false,"given":"Tom","family":"Lund","sequence":"additional","affiliation":[{"name":"5Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom."},{"name":"6Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom."},{"name":"7UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-3927","authenticated-orcid":false,"given":"Ayse U.","family":"Akarca","sequence":"additional","affiliation":[{"name":"8Department of Cellular Pathology, University College London Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rosenthal","sequence":"additional","affiliation":[{"name":"9Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kalinke","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3427-3926","authenticated-orcid":false,"given":"Deepak P.","family":"Chandrasekharan","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos P.","family":"Pipinikas","sequence":"additional","affiliation":[{"name":"10University College London Cancer Institute, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lee-Six","sequence":"additional","affiliation":[{"name":"11The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-8791","authenticated-orcid":false,"given":"Robert E.","family":"Hynds","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."},{"name":"9Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom."},{"name":"10University College London Cancer Institute, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate H.C.","family":"Gowers","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake Y.","family":"Henry","sequence":"additional","affiliation":[{"name":"3Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom."},{"name":"5Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0740-5436","authenticated-orcid":false,"given":"Fraser R.","family":"Millar","sequence":"additional","affiliation":[{"name":"12Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-6297","authenticated-orcid":false,"given":"Yeman B.","family":"Hagos","sequence":"additional","affiliation":[{"name":"2Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom."},{"name":"3Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Denais","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Falzon","sequence":"additional","affiliation":[{"name":"8Department of Cellular Pathology, University College London Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Moore","sequence":"additional","affiliation":[{"name":"7UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom."},{"name":"8Department of Cellular Pathology, University College London Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Antoniou","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal F.","family":"Durrenberger","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Furness","sequence":"additional","affiliation":[{"name":"5Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom."},{"name":"13The Royal Marsden NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Carroll","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-8772","authenticated-orcid":false,"given":"Claire","family":"Marceaux","sequence":"additional","affiliation":[{"name":"14Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-6076","authenticated-orcid":false,"given":"Marie-Liesse","family":"Asselin-Labat","sequence":"additional","affiliation":[{"name":"14Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia."},{"name":"15Knight Cancer Institute, Cancer Early Detection and Advanced Research (CEDAR) Center, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Larson","sequence":"additional","affiliation":[{"name":"16Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Betts","sequence":"additional","affiliation":[{"name":"16Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Coussens","sequence":"additional","affiliation":[{"name":"16Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky M.","family":"Thakrar","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"George","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[{"name":"7UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom."},{"name":"9Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom."},{"name":"10University College London Cancer Institute, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Thirlwell","sequence":"additional","affiliation":[{"name":"10University College London Cancer Institute, London, United Kingdom."},{"name":"17University of Exeter College of Medicine and Health, Exeter, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Campbell","sequence":"additional","affiliation":[{"name":"11The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1223-6275","authenticated-orcid":false,"given":"Teresa","family":"Marafioti","sequence":"additional","affiliation":[{"name":"8Department of Cellular Pathology, University College London Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Yuan","sequence":"additional","affiliation":[{"name":"2Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom."},{"name":"3Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Quezada","sequence":"additional","affiliation":[{"name":"5Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom."},{"name":"6Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom."},{"name":"7UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"McGranahan","sequence":"additional","affiliation":[{"name":"10University College London Cancer Institute, London, United Kingdom."},{"name":"18Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-5939","authenticated-orcid":false,"given":"Sam M.","family":"Janes","sequence":"additional","affiliation":[{"name":"1Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom."},{"name":"7UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2022060701063264200_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2559.2001.01078.x","article-title":"Reproducibility of the WHO\/IASLC grading system for pre-invasive squamous lesions of the bronchus: a study of inter-observer and intra-observer variation","volume":"38","author":"Nicholson","year":"2001","journal-title":"Histopathology"},{"key":"2022060701063264200_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","article-title":"Immune evasion before tumour invasion in early lung squamous carcinogenesis","volume":"571","author":"Mascaux","year":"2019","journal-title":"Nature"},{"key":"2022060701063264200_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/thx.2005.052191","article-title":"Surveillance for the detection of early lung cancer in patients with bronchial dysplasia","volume":"62","author":"George","year":"2007","journal-title":"Thorax"},{"key":"2022060701063264200_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","article-title":"Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions","volume":"25","author":"Teixeira","year":"2019","journal-title":"Nat Med"},{"key":"2022060701063264200_bib5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-020-0900-x","article-title":"Geospatial immune variability illuminates differential evolution of lung adenocarcinoma","volume":"26","author":"AbdulJabbar","year":"2020","journal-title":"Nat Med"},{"key":"2022060701063264200_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.celrep.2017.03.037","article-title":"Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis","volume":"19","author":"Tsujikawa","year":"2017","journal-title":"Cell Rep"},{"key":"2022060701063264200_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.mie.2019.05.039","article-title":"High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers","volume":"635","author":"Banik","year":"2020","journal-title":"Meth Enzymol"},{"key":"2022060701063264200_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","article-title":"Gene expression markers of tumor infiltrating leukocytes","volume":"5","author":"Danaher","year":"2017","journal-title":"J Immunother Cancer"},{"key":"2022060701063264200_bib9","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","article-title":"Pan-cancer deconvolution of tumour composition using DNA methylation","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat Commun"},{"key":"2022060701063264200_bib10","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-020-1961-1","article-title":"Tobacco smoking and somatic mutations in human bronchial epithelium","volume":"578","author":"Yoshida","year":"2020","journal-title":"Nature"},{"key":"2022060701063264200_bib11","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","article-title":"Neoantigen-directed immune escape in lung cancer evolution","volume":"567","author":"Rosenthal","year":"2019","journal-title":"Nature"},{"key":"2022060701063264200_bib12","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41467-019-09834-2","article-title":"Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions","volume":"10","author":"Beane","year":"2019","journal-title":"Nat Commun"},{"key":"2022060701063264200_bib13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"2022060701063264200_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/annonc\/mdx687","article-title":"Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma","volume":"29","author":"Ghorani","year":"2018","journal-title":"Ann Oncol"},{"key":"2022060701063264200_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"2022060701063264200_bib16","first-page":"536433","article-title":"Evolutionary dynamics of neoantigens in growing tumours","author":"Lakatos","year":"2019","journal-title":"bioRxiv"},{"key":"2022060701063264200_bib17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"2022060701063264200_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.immuni.2018.03.004","article-title":"Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape","volume":"48","author":"Wellenstein","year":"2018","journal-title":"Immunity"},{"key":"2022060701063264200_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal patterns of selection in cancer and somatic tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"key":"2022060701063264200_bib20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-specific HLA loss and immune escape in lung cancer evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"2022060701063264200_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ijc.29684","article-title":"Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes","volume":"138","author":"Gy\u0151rffy","year":"2016","journal-title":"Int J Cancer"},{"key":"2022060701063264200_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1399-0039.2009.01390.x","article-title":"Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer","volume":"75","author":"Ye","year":"2010","journal-title":"Tissue Antigens"},{"key":"2022060701063264200_bib23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"The Cancer Genome Stlas Research Network","year":"2012","journal-title":"Nature"},{"key":"2022060701063264200_bib24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2326-6066.CIR-15-0073","article-title":"Decitabine enhances lymphocyte migration and function and synergizes with CTLA-4 blockade in a murine ovarian cancer model","volume":"3","author":"Wang","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2022060701063264200_bib25","doi-asserted-by":"crossref","first-page":"e62924","DOI":"10.1371\/journal.pone.0062924","article-title":"Low dose decitabine treatment induces CD80 expression in cancer cells and stimulates tumor specific cytotoxic T lymphocyte responses","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"2022060701063264200_bib26","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/leu.2013.355","article-title":"Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents","volume":"28","author":"Yang","year":"2014","journal-title":"Leukemia"},{"key":"2022060701063264200_bib27","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1073\/pnas.0909797107","article-title":"Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers","volume":"107","author":"Saadi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060701063264200_bib28","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa1810865","article-title":"Pembrolizumab plus chemotherapy for squamous non\u2013small-cell lung cancer","volume":"379","author":"Paz-Ares","year":"2018","journal-title":"N Engl J Med"},{"key":"2022060701063264200_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/ijms20040824","article-title":"Role of PD-L1 expression in non-small cell lung cancer and their prognostic significance according to clinicopathological factors and diagnostic markers","volume":"20","author":"Pawelczyk","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2022060701063264200_bib30","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/s41467-019-10088-1","article-title":"Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with Fc\u03b3R affinity","volume":"10","author":"Qi","year":"2019","journal-title":"Nat Commun"},{"key":"2022060701063264200_bib31","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nat Med"},{"key":"2022060701063264200_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fonc.2015.00117","article-title":"4-1BB agonists: multi-potent potentiators of tumor immunity","volume":"5","author":"Bartkowiak","year":"2015","journal-title":"Front Oncol"},{"key":"2022060701063264200_bib33","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1078-0432.CCR-17-1922","article-title":"Phase I study of single-agent utomilumab (PF-05082566), a 4-1BB\/CD137 agonist, in patients with advanced cancer","volume":"24","author":"Segal","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2022060701063264200_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/gb-2006-7-12-243","article-title":"The chemokine and chemokine receptor superfamilies and their molecular evolution","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Genome Biol"},{"key":"2022060701063264200_bib35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1084\/jem.20030593","article-title":"Immune evasion by murine melanoma mediated through CC chemokine receptor-10","volume":"198","author":"Murakami","year":"2003","journal-title":"J Exp Med"},{"key":"2022060701063264200_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"GTEx Consortium","year":"2015","journal-title":"Science"},{"key":"2022060701063264200_bib37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/thoraxjnl-2013-204198","article-title":"Cell migration leads to spatially distinct but clonally related airway cancer precursors","volume":"69","author":"Pipinikas","year":"2014","journal-title":"Thorax"},{"key":"2022060701063264200_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"2022060701063264200_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","article-title":"ChAMP: 450k chip analysis methylation pipeline","volume":"30","author":"Morris","year":"2014","journal-title":"Bioinformatics"},{"key":"2022060701063264200_bib40","doi-asserted-by":"crossref","first-page":"15.10.1","DOI":"10.1002\/cpbi.20","article-title":"cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data","volume":"56","author":"Jones","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"2022060701063264200_bib41","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"2022060701063264200_bib42","doi-asserted-by":"crossref","first-page":"15.71","DOI":"10.1002\/0471250953.bi1507s52","article-title":"cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing","volume":"52","author":"Raine","year":"2015","journal-title":"Curr Protoc Bioinformatics"},{"key":"2022060701063264200_bib43","doi-asserted-by":"crossref","first-page":"15.9.1","DOI":"10.1002\/cpbi.17","article-title":"ascatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data","volume":"56","author":"Raine","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"2022060701063264200_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"key":"2022060701063264200_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Methods"},{"key":"2022060701063264200_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"key":"2022060701063264200_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"ImerTest Package: Tests in Linear Mixed Effects Models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J Stat Softw"},{"key":"2022060701063264200_bib48","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2022060701063264200_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1214\/aos\/1013699998","article-title":"The control of the false discovery rate in multiple testing under dependency","volume":"29","author":"Benjamini","year":"2001","journal-title":"Ann Statist"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/10\/1489\/1794891\/1489.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/10\/10\/1489\/1794891\/1489.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T21:07:17Z","timestamp":1654549637000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/10\/10\/1489\/6398\/Immune-Surveillance-in-Clinical-Regression-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-19-1366","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.22536944","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536926.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536935","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536941","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536935.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6548276","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536941.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6548276.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536944.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536938.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/833004","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536938","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536929.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536926","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22536929","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}